Advanced Therapies
This article was originally published in SRA
Executive Summary
Swissmedic issues guideline on gene therapy risks
You may also be interested in...
EU ‘Structured Dialog’ Offers Opportunity To Secure Supply
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Adcock Struggles As South African Healthcare Awaits Relief
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.
EMEA Round-Up: Bayer Strikes Egypt Deals, Orkla Acquires NutraQ, Uriach Grabs Sidroga
Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: